XML 35 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value of Assets and Liabilities Fair Value of Assets and Liabilities (Tables)
3 Months Ended
Mar. 31, 2017
Fair Value Disclosures [Abstract]  
Schedule Of Fair Value Assets and Liabilities Measured on Recurring Basis Table Text Block
Assets and liabilities measured at fair value on a recurring basis as of March 31, 2017 and December 31, 2016 are summarized below (dollars in thousands):
March 31, 2017:
 
 
 
Fair Value Measurements Using:
 
 
Total    
 
Level 1        
 
Level 2    
 
Level 3    
Assets:
 
 
 
 
 
 
 
 
Fixed maturity securities – available-for-sale:
 
 
 
 
 
 
 
 
Corporate securities
 
$
20,161,453

 
$
426,837

 
$
18,470,691

 
$
1,263,925

Canadian and Canadian provincial governments
 
3,720,364

 

 
3,236,804

 
483,560

Residential mortgage-backed securities
 
1,303,877

 

 
1,160,447

 
143,430

Asset-backed securities
 
1,380,590

 

 
1,172,154

 
208,436

Commercial mortgage-backed securities
 
1,289,338

 

 
1,287,415

 
1,923

U.S. government and agencies
 
1,482,452

 
1,360,357

 
98,621

 
23,474

State and political subdivisions
 
595,457

 

 
561,599

 
33,858

Other foreign government supranational and foreign government-sponsored enterprises
 
2,761,262

 
313,644

 
2,435,274

 
12,344

Total fixed maturity securities – available-for-sale
 
32,694,793

 
2,100,838

 
28,423,005

 
2,170,950

Funds withheld at interest – embedded derivatives
 
46,173

 

 

 
46,173

Cash equivalents
 
367,562

 
367,562

 

 

Short-term investments
 
24,929

 
1,615

 
20,038

 
3,276

Other invested assets:
 
 
 
 
 
 
 
 
Non-redeemable preferred stock
 
31,215

 
31,215

 

 

Other equity securities
 
80,401

 
80,401

 

 

Derivatives:
 
 
 
 
 
 
 
 
Interest rate swaps
 
50,011

 

 
50,011

 

Foreign currency forwards
 
139

 

 
139

 

Credit default swaps
 
5,128

 

 
5,128

 

Equity options
 
17,245

 

 
17,245

 

Foreign currency swaps
 
97,660

 

 
97,660

 

FVO contractholder-directed unit-linked investments
 
193,600

 
192,266

 
1,334

 

Other
 
8,192

 
8,192

 

 

Total other invested assets
 
483,591

 
312,074

 
171,517

 

Other assets - longevity swaps
 
29,170

 

 

 
29,170

Total
 
$
33,646,218

 
$
2,782,089

 
$
28,614,560

 
$
2,249,569

Liabilities:
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities – embedded derivatives
 
$
972,930

 
$

 
$

 
$
972,930

Other liabilities:
 
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
 
Interest rate swaps
 
14,702

 

 
14,702

 

Foreign currency forwards
 
3,377

 

 
3,377

 

CPI swaps
 
244

 

 
244

 

Credit default swaps
 
(665
)
 

 
(665
)
 

Equity options
 
(9,194
)
 

 
(9,194
)
 

Mortality swaps
 
2,857

 

 

 
2,857

Total
 
$
984,251

 
$

 
$
8,464

 
$
975,787

December 31, 2016:
 
 
 
Fair Value Measurements Using:
 
 
Total
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
 
Fixed maturity securities – available-for-sale:
 
 
 
 
 
 
 
 
Corporate securities
 
$
19,619,084

 
$
310,995

 
$
18,035,836

 
$
1,272,253

Canadian and Canadian provincial governments
 
3,644,046

 

 
3,168,081

 
475,965

Residential mortgage-backed securities
 
1,278,576

 

 
1,118,285

 
160,291

Asset-backed securities
 
1,429,344

 

 
1,210,064

 
219,280

Commercial mortgage-backed securities
 
1,363,654

 

 
1,342,509

 
21,145

U.S. government and agencies
 
1,468,302

 
1,345,755

 
98,059

 
24,488

State and political subdivisions
 
591,796

 

 
550,130

 
41,666

Other foreign government, supranational and foreign government-sponsored enterprises
 
2,698,823

 
276,729

 
2,409,225

 
12,869

Total fixed maturity securities – available-for-sale
 
32,093,625

 
1,933,479

 
27,932,189

 
2,227,957

Funds withheld at interest – embedded derivatives
 
(22,529
)
 

 

 
(22,529
)
Cash equivalents
 
338,601

 
338,601

 

 

Short-term investments
 
44,241

 
8,276

 
32,619

 
3,346

Other invested assets:
 
 
 
 
 
 
 
 
Non-redeemable preferred stock
 
51,123

 
38,317

 
12,806

 

Other equity securities
 
224,238

 
224,238

 

 

Derivatives:
 
 
 
 
 
 
 
 
Interest rate swaps
 
93,508

 

 
93,508

 

Credit default swaps
 
9,136

 

 
9,136

 

Equity options
 
26,070

 

 
26,070

 

Foreign currency swaps
 
100,394

 

 
100,394

 

FVO contractholder-directed unit-linked investments
 
190,120

 
188,891

 
1,229

 

Other
 
11,036

 
11,036

 

 

Total other invested assets
 
705,625

 
462,482

 
243,143

 

Other assets - longevity swaps
 
26,958

 

 

 
26,958

Total
 
$
33,186,521

 
$
2,742,838

 
$
28,207,951

 
$
2,235,732

Liabilities:
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities – embedded derivatives
 
$
990,308

 
$

 
$

 
$
990,308

Other liabilities:
 
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
 
Interest rate swaps
 
24,374

 

 
24,374

 

Foreign currency forwards
 
5,070

 

 
5,070

 

CPI swaps
 
262

 

 
262

 

Credit default swaps
 
(5
)
 

 
(5
)
 

Equity options
 
(7,389
)
 

 
(7,389
)
 

Foreign currency swaps
 
(3,231
)
 

 
(3,231
)
 

Mortality swaps
 
2,462

 

 

 
2,462

Total
 
$
1,011,851

 
$

 
$
19,081

 
$
992,770


Fair Value Unobservable Input Measurements [Table Text Block]
The following table presents quantitative information about significant unobservable inputs used in Level 3 fair value measurements that are developed internally by the Company as of March 31, 2017 and December 31, 2016 (dollars in thousands):
 
 
Estimated Fair Value      
 
Valuation Technique
 
Unobservable Inputs
 
Range (Weighted Average) 
March 31, 2017
 
December 31, 2016
 
 
 
March 31, 2017
 
December 31, 2016
Assets:
 
 
 
 
 
 
 
 
 
 
 
Corporate securities
$158,772
 
$167,815
 
Market comparable securities
 
Liquidity premium
 
0-2% (1%)

 
0-2%  (1%)

U.S. government and agencies
23,474

 
24,488

 
Market comparable securities
 
Liquidity premium
 
0-1% (1%)

 
0-1%  (1%)

State and political subdivisions
4,653

 
4,670

 
Market comparable securities    
 
Liquidity premium
 
1
%
 
1
%
Funds withheld at interest- embedded derivatives
46,173

 
(22,529
)
 
Total return swap
 
Mortality
 
0-100%  (2%)

 
0-100%  (2%)

 
 
 
 
 
 
 
Lapse
 
0-35%  (8%)

 
0-35%  (8%)

 
 
 
 
 
 
 
Withdrawal
 
0-5%  (3%)

 
0-5%  (3%)

 
 
 
 
 
 
 
CVA
 
0-5%  (1%)

 
0-5%  (1%)

 
 
 
 
 
 
 
Crediting rate
 
2-4%  (2%)

 
2-4%  (2%)

Longevity swaps
29,170

 
26,958

 
Discounted cash flow
 
Mortality
 
0-100%  (2%)

 
0-100%  (2%)

 
 
 
 
 
 
 
Mortality improvement
 
(10%)-10%  (3%)

 
(10%)-10%  (3%)

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities- embedded derivatives- indexed annuities
810,657

 
805,672

 
Discounted cash flow
 
Mortality
 
0-100%  (2%)

 
0-100% (2%)

 
 
 
 
 
 
 
Lapse
 
0-35%  (8%)

 
0-35% (8%)

 
 
 
 
 
 
 
Withdrawal
 
0-5%  (3%)

 
0-5% (3%)

 
 
 
 
 
 
 
Option budget projection
 
2-4%  (2%)

 
2-4% (2%)

Interest sensitive contract liabilities- embedded derivatives- variable annuities
162,273

 
184,636

 
Discounted cash 
flow
 
Mortality
 
0-100% (2%)

 
0-100% (2%)

 
 
 
 
 
 
 
Lapse
 
0-25% (6%)

 
0-25% (6%)

 
 
 
 
 
 
 
Withdrawal
 
0-7% (3%)

 
0-7% (3%)

 
 
 
 
 
 
 
CVA
 
0-5% (1%)

 
0-5% (1%)

 
 
 
 
 
 
 
Long-term volatility
 
0-27% (9%)

 
0-27% (14%)

Mortality swaps
2,857

 
2,462

 
Discounted cash flow
 
Mortality
 
0-100%  (1%)

 
0-100%  (1%)

Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block]
The following table presents quantitative information about significant unobservable inputs used in Level 3 fair value measurements that are developed internally by the Company as of March 31, 2017 and December 31, 2016 (dollars in thousands):
 
 
Estimated Fair Value      
 
Valuation Technique
 
Unobservable Inputs
 
Range (Weighted Average) 
March 31, 2017
 
December 31, 2016
 
 
 
March 31, 2017
 
December 31, 2016
Assets:
 
 
 
 
 
 
 
 
 
 
 
Corporate securities
$158,772
 
$167,815
 
Market comparable securities
 
Liquidity premium
 
0-2% (1%)

 
0-2%  (1%)

U.S. government and agencies
23,474

 
24,488

 
Market comparable securities
 
Liquidity premium
 
0-1% (1%)

 
0-1%  (1%)

State and political subdivisions
4,653

 
4,670

 
Market comparable securities    
 
Liquidity premium
 
1
%
 
1
%
Funds withheld at interest- embedded derivatives
46,173

 
(22,529
)
 
Total return swap
 
Mortality
 
0-100%  (2%)

 
0-100%  (2%)

 
 
 
 
 
 
 
Lapse
 
0-35%  (8%)

 
0-35%  (8%)

 
 
 
 
 
 
 
Withdrawal
 
0-5%  (3%)

 
0-5%  (3%)

 
 
 
 
 
 
 
CVA
 
0-5%  (1%)

 
0-5%  (1%)

 
 
 
 
 
 
 
Crediting rate
 
2-4%  (2%)

 
2-4%  (2%)

Longevity swaps
29,170

 
26,958

 
Discounted cash flow
 
Mortality
 
0-100%  (2%)

 
0-100%  (2%)

 
 
 
 
 
 
 
Mortality improvement
 
(10%)-10%  (3%)

 
(10%)-10%  (3%)

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
Interest sensitive contract liabilities- embedded derivatives- indexed annuities
810,657

 
805,672

 
Discounted cash flow
 
Mortality
 
0-100%  (2%)

 
0-100% (2%)

 
 
 
 
 
 
 
Lapse
 
0-35%  (8%)

 
0-35% (8%)

 
 
 
 
 
 
 
Withdrawal
 
0-5%  (3%)

 
0-5% (3%)

 
 
 
 
 
 
 
Option budget projection
 
2-4%  (2%)

 
2-4% (2%)

Interest sensitive contract liabilities- embedded derivatives- variable annuities
162,273

 
184,636

 
Discounted cash 
flow
 
Mortality
 
0-100% (2%)

 
0-100% (2%)

 
 
 
 
 
 
 
Lapse
 
0-25% (6%)

 
0-25% (6%)

 
 
 
 
 
 
 
Withdrawal
 
0-7% (3%)

 
0-7% (3%)

 
 
 
 
 
 
 
CVA
 
0-5% (1%)

 
0-5% (1%)

 
 
 
 
 
 
 
Long-term volatility
 
0-27% (9%)

 
0-27% (14%)

Mortality swaps
2,857

 
2,462

 
Discounted cash flow
 
Mortality
 
0-100%  (1%)

 
0-100%  (1%)

Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Level Transfers [Table Text Block]
The following table presents the transfers between Level 1 and Level 2 during the three months ended March 31, 2017 (dollars in thousands):
 
 
2017
 
 
Transfers from    
Level 1 to
Level 2
 
Transfers from    
Level 2 to
Level 1
Fixed maturity securities - available-for-sale:
 
 
 
 
Corporate securities
 
$

 
$
38,675

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The tables below provide a summary of the changes in fair value of Level 3 assets and liabilities for the three months ended March 31, 2017, as well as the portion of gains or losses included in income for the three months ended March 31, 2017 attributable to unrealized gains or losses related to those assets and liabilities still held at March 31, 2017 (dollars in thousands):
For the three months ended March 31, 2017:
 
Fixed maturity securities - available-for-sale
 
 
Corporate
securities
 
Canadian and Canadian provincial governments
 
Residential
mortgage-
backed
securities
 
Asset-backed
securities
 
Commercial    
mortgage-
backed
securities
 
U.S. government
and agencies
Fair value, beginning of period
 
$
1,272,253

 
$
475,965

 
$
160,291

 
$
219,280

 
$
21,145

 
$
24,488

Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
(423
)
 
3,070

 
(245
)
 
1,018

 
709

 
(117
)
Investment related gains (losses), net
 
(1,231
)
 

 
365

 

 
(595
)
 

Included in other comprehensive income
 
4,948

 
4,525

 
650

 
5,767

 
(83
)
 
52

Other revenues
 

 

 

 

 

 

Purchases(1)
 
45,914

 

 
16,499

 
10,849

 

 
104

Sales(1)
 

 

 
(10,604
)
 

 
(3,720
)
 

Settlements(1)
 
(71,470
)
 

 
(6,784
)
 
(18,154
)
 
(5,401
)
 
(1,053
)
Transfers into Level 3
 
13,934

 

 
77

 
35,258

 

 

Transfers out of Level 3
 

 

 
(16,819
)
 
(45,582
)
 
(10,132
)
 

Fair value, end of period
 
$
1,263,925

 
$
483,560

 
$
143,430

 
$
208,436

 
$
1,923

 
$
23,474

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$
(423
)
 
$
3,070

 
$
(91
)
 
$
161

 
$

 
$
(117
)
Investment related gains (losses), net
 
(1,293
)
 

 
(346
)
 

 

 

 
For the three months ended March 31, 2017 (continued):
 
Fixed maturity securities
available-for-sale
 
 
 
 
 
 
 
 
 
 
 
 
State
and political
subdivisions
 
Other foreign government, supranational and foreign government-sponsored enterprises
 
Short-term Investments
 
Funds withheld
at interest-
embedded
derivatives
 
Other assets - longevity swaps
 
Interest sensitive contract liabilities embedded derivatives
 
Other liabilities - mortality swaps
Fair value, beginning of period
 
$
41,666

 
$
12,869

 
$
3,346

 
$
(22,529
)
 
$
26,958

 
$
(990,308
)
 
$
(2,462
)
Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
(88
)
 

 

 

 

 

 

Investment related gains (losses), net
 

 

 

 
68,702

 

 
22,362

 

Interest credited
 

 

 

 

 

 
(16,402
)
 

Included in other comprehensive income
 
(843
)
 
(191
)
 
33

 

 
347

 

 

Other revenues
 

 

 

 

 
1,865

 

 
(395
)
Purchases(1)
 

 

 
32

 

 

 
(6,393
)
 

Settlements(1)
 
(33
)
 
(334
)
 
(135
)
 

 

 
17,811

 

Transfers out of Level 3
 
(6,844
)
 

 

 

 

 

 

Fair value, end of period
 
$
33,858

 
$
12,344


$
3,276

 
$
46,173

 
$
29,170

 
$
(972,930
)
 
$
(2,857
)
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$
(88
)
 
$

 
$

 
$

 
$

 
$

 
$

Investment related gains (losses), net
 

 

 

 
68,702

 

 
20,300

 

Other revenues
 

 

 

 

 
1,865

 

 
(395
)
Interest credited
 

 

 

 

 

 
(34,214
)
 


(1)
The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.

The tables below provide a summary of the changes in fair value of Level 3 assets and liabilities for the three months ended March 31, 2016, as well as the portion of gains or losses included in income for the three months ended March 31, 2016 attributable to unrealized gains or losses related to those assets and liabilities still held at March 31, 2016 (dollars in thousands):
For the three months ended March 31, 2016:
 
Fixed maturity securities - available-for-sale
 
 
Corporate
securities
 
Canadian and Canadian provincial governments
 
Residential
mortgage-
backed
securities
 
Asset-backed
securities
 
Commercial    
mortgage-
backed
securities
 
U.S. government
and agencies
Fair value, beginning of period
 
$
1,226,970

 
$
416,076

 
$
330,649

 
$
303,836

 
$
68,563

 
$
26,265

Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
(827
)
 
3,002

 
(487
)
 
174

 
643

 
(123
)
Investment related gains (losses), net
 
(21,868
)
 

 
(31
)
 
278

 
(620
)
 

Included in other comprehensive income
 
25,682

 
68,305

 
(4,332
)
 
(10,527
)
 
(2,812
)
 
596

Purchases(1)
 
67,596

 

 
29,315

 
37,271

 
1,545

 
113

Sales(1)
 
(9,582
)
 

 
(448
)
 
(8,500
)
 
(3,638
)
 

Settlements(1)
 
(49,494
)
 

 
(11,440
)
 
(3,725
)
 
(69
)
 
(971
)
Transfers into Level 3
 
5,183

 

 
38

 
6,398

 

 

Transfers out of Level 3
 

 

 
(10,011
)
 
(39,985
)
 
(38
)
 

Fair value, end of period
 
$
1,243,660

 
$
487,383

 
$
333,253

 
$
285,220

 
$
63,574

 
$
25,880

Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$
(820
)
 
$
3,002

 
$
(488
)
 
$
163

 
$
546

 
$
(123
)
Investment related gains (losses), net
 
(21,726
)
 

 

 

 
(657
)
 

 
For the three months ended March 31, 2016 (continued):
 
Fixed maturity securities
available-for-sale
 
 
 
 
 
 
 
 
 
 
State
and political
subdivisions
 
Other foreign government, supranational and foreign government-sponsored enterprises
 
Funds withheld
at interest-
embedded
derivatives
 
Other assets - longevity swaps
 
Interest sensitive contract liabilities embedded derivatives
 
Other liabilities - mortality swaps
Fair value, beginning of period
 
$
38,342

 
$
14,065

 
$
(76,698
)
 
$
14,996

 
$
(1,070,584
)
 
$
(2,619
)
Total gains/losses (realized/unrealized)
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
183

 

 

 

 

 

Investment related gains (losses), net
 

 

 
(92,250
)
 

 
(62,940
)
 

Interest credited
 

 

 

 

 
1,394

 

Included in other comprehensive income
 
333

 
193

 

 
723

 

 

Other revenues
 

 

 

 
87

 

 
(424
)
Purchases(1)
 

 

 

 

 
(2,668
)
 

Settlements(1)
 
(31
)
 
(322
)
 

 

 
16,729

 

Transfers out of Level 3
 
(4,203
)
 

 

 

 

 

Fair value, end of period
 
$
34,624

 
$
13,936

 
$
(168,948
)
 
$
15,806

 
$
(1,118,069
)
 
$
(3,043
)
Unrealized gains and losses recorded in earnings for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
 
 
 
 
 
 
 
 
 
 
 
 
Included in earnings, net:
 
 
 
 
 
 
 
 
 
 
 
 
Investment income, net of related expenses
 
$
183

 
$

 
$

 
$

 
$

 
$

Investment related gains (losses), net
 

 

 
(92,250
)
 

 
(65,479
)
 

Other revenues
 

 

 

 
87

 

 
(424
)
Interest credited
 

 

 

 

 
(15,335
)
 



(1)
The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis [Table Text Block]
The following table presents information for assets measured at estimated fair value on a nonrecurring basis during the three months ended March 31, 2016 and still held at the reporting date (for example, when there is evidence of impairment). The estimated fair values for these assets were determined using significant unobservable inputs (Level 3).
(dollars in thousands)
 
Carrying Value
After Measurement
 
Net Investment
Gains (Losses)
Mortgage loans(1)
 
$
9,663

 
$
(302
)
Limited partnership interests(2)
 
4,298

 
(2,053
)
 
(1)
Estimated fair values for impaired mortgage loans are based on internal valuation models using unobservable inputs or, if the loans are in foreclosure or are otherwise determined to be collateral dependent, are based on external appraisals of the underlying collateral.
(2)
The impaired limited partnership interests presented above were accounted for using the cost method. Impairments on these cost method investments were recognized at estimated fair value determined using the net asset values of the Company’s ownership interest as provided in the financial statements of the investees. The market for these investments has limited activity and price transparency.
Financial Instruments Carrying Amounts And Estimated Fair Value [Table Text Block]
The following table presents the carrying amounts and estimated fair values of the Company’s financial instruments, which were not measured at fair value on a recurring basis, at March 31, 2017 and December 31, 2016 (dollars in thousands). This table excludes any payables or receivables for collateral under repurchase agreements and other transactions. The estimated fair value of the excluded amount approximates carrying value as they equal the amount of cash collateral received/paid.
March 31, 2017:
 
Carrying Value    
 
Estimated 
Fair Value
 
Fair Value Measurement Using:
Level 1
 
Level 2
 
Level 3
 
NAV
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage loans on real estate
 
$
3,871,309

 
$
3,909,506

 
$

 
$

 
$
3,909,506

 
$

Policy loans
 
1,402,940

 
1,402,940

 

 
1,402,940

 

 

Funds withheld at interest(1)
 
5,895,159

 
6,202,931

 

 

 
6,202,931

 

Cash and cash equivalents(2)
 
810,552

 
810,552

 
810,552

 

 

 

Short-term investments(2)
 
29,359

 
29,359

 
29,359

 

 

 

Other invested assets(2)
 
523,365

 
555,707

 
26,802

 
60,492

 
167,947

 
300,466

Accrued investment income
 
360,225

 
360,225

 

 
360,225

 

 

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Interest-sensitive contract liabilities(1)
 
$
10,279,136

 
$
10,237,636

 
$

 
$

 
$
10,237,636

 
$

Long-term debt
 
2,788,619

 
2,964,610

 

 

 
2,964,610

 

Collateral finance and securitization notes
 
825,526

 
732,353

 

 

 
732,353

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2016:
 
Carrying Value
 
Estimated
Fair Value
 
Fair Value Measurement Using:
Level 1
 
Level 2
 
Level 3
 
NAV
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage loans on real estate
 
$
3,775,522

 
$
3,786,987

 
$

 
$

 
$
3,786,987

 
$

Policy loans
 
1,427,602

 
1,427,602

 

 
1,427,602

 

 

Funds withheld at interest(1)
 
5,893,381

 
6,193,166

 

 

 
6,193,166

 

Cash and cash equivalents(2)
 
862,117

 
862,117

 
862,117

 

 

 

Short-term investments(2)
 
32,469

 
32,469

 
32,469

 

 

 

Other invested assets(2)
 
477,132

 
510,640

 
26,294

 
55,669

 
131,904

 
296,773

Accrued investment income
 
347,173

 
347,173

 

 
347,173

 

 

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
Interest-sensitive contract liabilities(1)
 
$
10,225,099

 
$
10,234,544

 
$

 
$

 
$
10,234,544

 
$

Long-term debt
 
3,088,635

 
3,186,173

 

 

 
3,186,173

 

Collateral finance and securitization notes
 
840,700

 
745,805

 

 

 
745,805

 

 
(1)
Carrying values presented herein differ from those presented in the condensed consolidated balance sheets because certain items within the respective financial statement caption are embedded derivatives and are measured at fair value on a recurring basis.
(2)
Carrying values presented herein differ from those presented in the condensed consolidated balance sheets because certain items within the respective financial statement caption are measured at fair value on a recurring basis.